EMILY ROBINSON: Open Payments
NPI 1356031769 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,904 in 85 payments from 17 companies in 2025. Trend: 2023 $708 · 2024 $2,412 · 2025 $2,904
Food & beverage: $2,853Education: $51
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $495 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $394 |
| Janssen Biotech, Inc. | 13 | $368 |
| ABBVIE INC. | 8 | $344 |
| Intercept Pharmaceuticals, Inc. | 5 | $186 |
| Phathom Pharmaceuticals, Inc. | 3 | $185 |
| Celltrion USA Inc. | 3 | $175 |
| Gilead Sciences, Inc. | 6 | $152 |
| Lilly USA, LLC | 2 | $151 |
| Regeneron Healthcare Solutions, Inc. | 1 | $127 |
Products named: REZDIFFRA, TREMFYA, ENTYVIO, SKYRIZI, OCALIVA, DUPIXENT, VOQUEZNA, OMVOH.
Industry payments across FL — which companies pay providers there.
